ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VXRT Vaxart Inc

0.71
0.0516 (7.84%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,321,643
Bid Price 0.71
Ask Price 0.72
News -
Day High 0.7097

Low
0.53

52 Week Range

High
1.59

Day Low 0.6603
Share Name Share Symbol Market Stock Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0516 7.84% 0.71 17:28:42
Open Price Low Price High Price Close Price Previous Close
0.6985 0.6603 0.7097 0.7097 0.6584
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,680 1,321,643 US$ 0.6871195 US$ 908,127 - 0.53 - 1.59
Last Trade Type Quantity Price Currency
18:51:28 formt 1,000 US$ 0.71 USD

Vaxart Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
123.44M 173.86M - 7.38M -82.47M -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vaxart News

Date Time Source News Article
3/27/202407:00GlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Washington 2024..
3/20/202407:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
3/14/202415:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Full Year 2023..
3/14/202406:41IH Market NewsU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil..
3/07/202407:00GlobeNewswire Inc.Vaxart to Host Full Year 2023 Business Update and Financial..
3/06/202408:23Edgar (US Regulatory)Form 8-K - Current report
3/06/202407:00GlobeNewswire Inc.Vaxart, Inc. Appoints Steven Lo as President, Chief..
2/29/202415:30Edgar (US Regulatory)Form 8-K - Current report
2/15/202415:10Edgar (US Regulatory)Form 8-K - Current report
2/13/202416:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/05/202407:00GlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Non-Human..
2/02/202415:49Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VXRT Message Board. Create One! See More Posts on VXRT Message Board See More Message Board Posts

Historical VXRT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.820.85680.63310.72187261,560,934-0.11-13.41%
1 Month1.331.340.63310.97097731,657,447-0.62-46.62%
3 Months1.201.540.63311.151,721,431-0.49-40.83%
6 Months0.63411.540.530.98549861,510,5290.075911.97%
1 Year0.731.590.530.95142771,555,231-0.02-2.74%
3 Years5.6811.1080.535.764,002,974-4.97-87.50%
5 Years0.681624.900.25436.726,435,8250.02844.17%

Vaxart Description

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Your Recent History

Delayed Upgrade Clock